Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ruthenium Catalyzed Hydroarylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115925527A details a Ru-catalyzed hydroarylation for alpha-diarylmethyl ketones, offering high selectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN112876507B details a Ru-catalyzed hydroarylation method for trisubstituted olefin phosphines, offering high yields up to 90% and reduced costs for pharma intermediates.